CELLCOR FOUNDER HONORED ...Cellcor Therapies Inc., a developer of autolymphocyte therapyfor advanced kidney cancer, said Michael E. Osband, M.D., chieftechnical officer and company founder, received the HenryChristian Award for Excellence in Research in oncology fromthe American Federation of Clinical Research. ...

Cellular Products Inc. (NASDAQ:CELP), a Buffalo, N.Y., developerof blood screening tests for AIDS and HTLV-1, said that MarcoPater has been elected chairman. Pater is president ofFinsystems (U.S.A.) Inc., whose parent company, FinsystemsS.r.l. of Italy, recently purchased 25 percent of CellularProducts' common stock. ...

Celtrix Laboratories Inc. (NASDAQ:CTRX) of Palo Alto, Calif., hasadded Timothy J. Wollaeger to its board. Wollaeger is seniorvice president of Columbia Hospital Corp. and president of itsSutter Corp. medical products subsidiary, as well as generalpartner in Biovest Partners, a venture capital firm. Celtrix, aspinoff of Collagen Corp., is developing TGFB (transforminggrowth factor beta) as a treatment for repairing detachedretinas. ...

Collagen Corp. (NASDAQ:CGEN), a Palo Alto, Calif., developer ofskin replacement and enhancement products, has added CraigJohnson, a senior member of the law firm Wilson, Sonsini,Goodrich and Rosati, to its board of directors. ...

Somatix Therapy Corp. (NASDAQ:SOMA) of Alameda, Calif., saidRobert Higgins, who had been director of Somatix Corp. prior toits merger with Hana Biologics Inc., has resigned from its boardof directors. Higgins cited time limitations and the relocation ofthe Somatix Corp. from Boston to Alameda as the reasons forhis decision.

(c) 1997 American Health Consultants. All rights reserved.